Expression signature of E2F1 and its associated genes predict superficial to invasive progression of bladder tumors

Journal of Clinical Oncology

Volumn 28, Issue 16, 2010, Pages 2660-2667

  Lee, Ju Seog ^a   Leem, Sun Hee ^a   Lee, Sang Yeop ^a   Kim, Sang Cheol ^a   Park, Eun Sung ^a   Kim, Sang Bae ^a   Kim, Seon Kyu ^a   Kim, Yong June ^a   Kim, Wun Jae ^a   Chu, In Sun ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR E2F1; RNA; TRANSCRIPTION FACTOR E2F2;

ADULT; AGED; ARTICLE; BLADDER TUMOR; CANCER GROWTH; CANCER INVASION; CANCER RISK; COHORT ANALYSIS; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; VALIDATION PROCESS; ANALYSIS OF VARIANCE; CANCER STAGING; COMPARATIVE STUDY; CYSTOSCOPY; DISEASE COURSE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; METHODOLOGY; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; NEEDLE BIOPSY; PATHOLOGY; PREDICTION AND FORECASTING; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SURVIVAL; TRANSITIONAL CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BIOPSY, NEEDLE; CARCINOMA, TRANSITIONAL CELL; COHORT STUDIES; CYSTOSCOPY; DISEASE PROGRESSION; E2F2 TRANSCRIPTION FACTOR; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RNA, NEOPLASM; SURVIVAL ANALYSIS; URINARY BLADDER NEOPLASMS; YOUNG ADULT;

EID: 77954928123     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2009.25.0977     Document Type: Article

References (38)

1. Parkin DM, Bray F, Ferlay J, et al: Global cancer statistics, 2002. CA Cancer J Clin 55:74-108, 2005
2. Jemal A, Siegel R, Ward E, et al: Cancer statistics, 2009. CA Cancer J Clin 59:225-249, 2009
3. Dinney CP, McConkey DJ, Millikan RE, et al: Focus on bladder cancer. Cancer Cell 6:111-116, 2004 (Pubitemid 39485683)
4. Wu XR: Urothelial tumorigenesis: A tale of divergent pathways. Nat Rev Cancer 5:713-725, 2005
5. Steinberg GD, Trump DL, Cummings KB: Metastatic bladder cancer: Natural history, clinical course, and consideration for treatment. Urol Clin North Am 19:735-746, 1992
6. Liebert M, Seigne J: Characteristics of invasive bladder cancers: Histological and molecular markers. Semin Urol Oncol 14:62-72, 1996 (Pubitemid 26154973)
7. Pow-Sang JM, Seigne JD: Contemporary management of superficial bladder cancer. Cancer Control 7:335-339, 2000 (Pubitemid 30602199)
8. Herr HW: Tumour progression and survival in patients with T1G3 bladder tumours: 15-year outcome. Br J Urol 80:762-765, 1997
9. Holmäng S, Hedelin H, Anderstrom C, et al: Recurrence and progression in low grade papillary urothelial tumors. J Urol 162:702-707, 1999 (Pubitemid 29436854)
10. Lee SE, Jeong IG, Ku JH, et al: Impact of transurethral resection of bladder tumor: Analysis of cystectomy specimens to evaluate for residual tumor. Urology 63:873-877, 2004 (Pubitemid 38596668)
11. Holmang S, Johansson SL: Stage Ta-T1 bladder cancer: The relationship between findings at first followup cystoscopy and subsequent recurrence and progression. J Urol 167:1634-1637, 2002 (Pubitemid 34240688)
12. Alizadeh AA, Eisen MB, Davis RE, et al: Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403:503-511, 2000 (Pubitemid 30082188)
13. van de Vijver MJ, He YD, van't Veer LJ, et al: A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347:1999-2009, 2002
14. Lee JS, Chu IS, Heo J, et al: Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling. Hepatology 40:667-676, 2004 (Pubitemid 39265589)
15. Hall MC, Chang SS, Dalbagni G, et al: Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update. J Urol 178:2314-2330, 2007
16. Bolstad BM, Irizarry RA, Astrand M, et al: A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19:185-193, 2003 (Pubitemid 36181903)
17. Simon R, Lam A, Li M-C, et al: Analysis of gene expression data using BRB-Array Tools. Cancer Inform 3:11-17, 2006
18. Wright GW, Simon RM: A random variance model for detection of differential gene expression in small microarray experiments. Bioinformatics 19: 2448-2455, 2003 (Pubitemid 38016644)
19. Pavlidis P, Qin J, Arango V, et al: Using the gene ontology for microarray data mining: A comparison of methods and application to age effects in human prefrontal cortex. Neurochem Res 29:1213-1222, 2004 (Pubitemid 39023495)
20. Radmacher MD, McShane LM, Simon R: A paradigm for class prediction using gene expression profiles. J Comput Biol 9:505-511, 2002 (Pubitemid 34920572)
21. Dudoit S, Fridlyand F, Speed TP: Comparison of discrimination methods for classification of tumors using DNA microarrays. J Am Stat Assoc 97:77-87, 2002
22. Ramaswamy S, Tamayo P, Rifkin R, et al: Multiclass cancer diagnosis using tumor gene expression signatures. Proc Natl Acad Sci U S A 98:15149-15154, 2001 (Pubitemid 34013984)
23. Simon R, Radmacher MD, Dobbin K, et al: Pitfalls in the use of DNA microarray data for diagnostic and prognostic classification. J Natl Cancer Inst 95:14-18, 2003 (Pubitemid 36124291)
24. Sanchez-Carbayo M, Socci ND, Lozano J, et al: Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays. J Clin Oncol 24:778-789, 2006 (Pubitemid 46622045)
25. Dyrskjøt L, Thykjaer T, Kruhoffer M, et al: Identifying distinct classes of bladder carcinoma using microarrays. Nat Genet 33:90-96, 2003 (Pubitemid 36068689)
26. Kim SB, Yang S, Kim SK, et al: GAzer: Gene set analyzer. Bioinformatics 23:1697-1699, 2007 (Pubitemid 47244463)
27. Subramanian A, Tamayo P, Mootha VK, et al: Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102:15545-15550, 2005 (Pubitemid 41528093)
28. Bild AH, Yao G, Chang JT, et al: Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature 439:353-357, 2006 (Pubitemid 43128862)
29. Nevins JR: The Rb/E2F pathway and cancer. Hum Mol Genet 10:699-703, 2001
30. Stevaux O, Dyson NJ: A revised picture of the E2F transcriptional network and RB function. Curr Opin Cell Biol 14:684-691, 2002 (Pubitemid 35449380)
31. Dyrskjøt L, Zieger K, Real FX, et al: Gene expression signatures predict outcome in nonmuscle-invasive bladder carcinoma: A multicenter validation study. Clin Cancer Res 13:3545-3551, 2007 (Pubitemid 46955114)
32. Lee JS, Chu IS, Mikaelyan A, et al: Application of comparative functional genomics to identify best-fit mouse models to study human cancer. Nat Genet 36:1306-1311, 2004 (Pubitemid 39577940)
33. Lee JS, Heo J, Libbrecht L, et al: A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells. Nat Med 12:410-416, 2006
34. Kattan MW: Evaluating a new marker's predictive contribution. Clin Cancer Res 10:822-824, 2004
35. Kattan MW: Judging new markers by their ability to improve predictive accuracy. J Natl Cancer Inst 95:634-635, 2003
36. Dyson N: The regulation of E2F by pRB-family proteins. Genes Dev 12:2245-2262, 1998
37. Cote RJ, Dunn MD, Chatterjee SJ, et al: Elevated and absent pRb expression is associated with bladder cancer progression and has cooperative effects with p53. Cancer Res 58:1090-1094, 1998 (Pubitemid 28183188)
38. Cairns P, Proctor AJ, Knowles MA: Loss of heterozygosity at the RB locus is frequent and correlates with muscle invasion in bladder carcinoma. Oncogene 6:2305-2309, 1991 (Pubitemid 21924078)